These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 17125989)

  • 1. Recombinant factor VIIa in massive postpartum haemorrhage.
    Karalapillai D; Popham P
    Int J Obstet Anesth; 2007 Jan; 16(1):29-34. PubMed ID: 17125989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of recombinant activated factor VII in massive obstetric haemorrhage.
    Haynes J; Laffan M; Plaat F
    Int J Obstet Anesth; 2007 Jan; 16(1):40-9. PubMed ID: 17126006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant factor VIIa should be used in massive obstetric haemorrhage.
    Van de Velde M
    Int J Obstet Anesth; 2007 Oct; 16(4):357-9. PubMed ID: 17702565
    [No Abstract]   [Full Text] [Related]  

  • 4. Recombinant factor VIIa should be used in massive obstetric haemorrhage.
    Plaat F
    Int J Obstet Anesth; 2007 Oct; 16(4):354-7. PubMed ID: 17698342
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant factor VIIa for major obstetric haemorrhage in a Jehovah's Witness.
    Laird R; Carabine U
    Int J Obstet Anesth; 2008 Apr; 17(2):193-4. PubMed ID: 18308545
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful use of recombinant factor VIIa for treatment of severe postpartum hemorrhage.
    Hamaekers AE; van Mook WN; Offermans JP; Marcus MA
    Am J Crit Care; 2006 Jul; 15(4):399-401. PubMed ID: 16823017
    [No Abstract]   [Full Text] [Related]  

  • 7. [Life-threatening postpartum hemorrhage and recombinant activated factor rFVIIa NovoSeven use].
    Courtois L; Becher P; Miot S; Maisonnette-Escot Y; Sautière JL; Berthier F; Samain E; Maillet R; Riethmuller D
    J Gynecol Obstet Biol Reprod (Paris); 2007 Feb; 36(1):78-82. PubMed ID: 17293258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of recombinant factor VIIa for the management of massive bleeding due to uterine atonia in the post-placental period.
    Tanchev S; Platikanov V; Karadimov D
    Acta Obstet Gynecol Scand; 2005 Apr; 84(4):402-3. PubMed ID: 15762974
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage.
    Nicklin J; Perrin L; Crandon A; Land R; Nascimento M; Obermair A
    Aust N Z J Obstet Gynaecol; 2008 Aug; 48(4):447. PubMed ID: 18837857
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry.
    Phillips LE; McLintock C; Pollock W; Gatt S; Popham P; Jankelowitz G; Ogle R; Cameron PA;
    Anesth Analg; 2009 Dec; 109(6):1908-15. PubMed ID: 19923520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged treatment of massive postpartum haemorrhage with recombinant factor VIIa: case report and review of the literature.
    Boehlen F; Morales MA; Fontana P; Ricou B; Irion O; de Moerloose P
    BJOG; 2004 Mar; 111(3):284-7. PubMed ID: 14961895
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe gastrointestinal haemorrhage responding to recombinant factor VIIa in a Jehovah's Witness with refractory immune thrombocytopenia.
    Virchis A; Hughes C; Berney S
    Hematol J; 2004; 5(3):281-2. PubMed ID: 15167918
    [No Abstract]   [Full Text] [Related]  

  • 13. Preferences of Jehovah's Witnesses regarding haematological supports in an obstetric setting: experience of a single university teaching hospital.
    Husarova V; Donnelly G; Doolan A; Garstka M; Ni Ainle F; McCaul C
    Int J Obstet Anesth; 2016 Feb; 25():53-7. PubMed ID: 26597403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recombinant factor VIIa for treatment of postpartum hemorrhage due to uterine atony].
    Michalska-Krzanowska G
    Ginekol Pol; 2010 Jul; 81(7):544-8. PubMed ID: 20825059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant factor VIIa in massive obstetric haemorrhage.
    Bhuskute N; Kritzinger S; Dakin M
    Eur J Anaesthesiol; 2008 Mar; 25(3):250-1. PubMed ID: 18226279
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant activated factor VII for a warfarinised Jehovah's Witness with an acute subdural haematoma.
    Goldberg R; Drummond KJ
    J Clin Neurosci; 2008 Oct; 15(10):1164-6. PubMed ID: 17702584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Obstetric Surgery with High Risk of Postpartum Hemorrhage in a Jehovah's Witness].
    Carp M; Maurício S; Lança F
    Acta Med Port; 2021 Mar; 34(4):300-303. PubMed ID: 34214421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of recombinant activated Factor VII in major obstetric haemorrhage: the Farnborough experience.
    Wissa I; Ebeid E; El-Shawarby S; Chandakas S; Kamal T; Hill N
    J Obstet Gynaecol; 2009 Jan; 29(1):21-4. PubMed ID: 19280490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of recombinant factor VIIa for the control of massive bleeding caused by uterine hypotonia in post-placental period].
    Tanchev S; Platikanov V; Markova S; Slavov N; Bogdanova A; Dimitrova D
    Akush Ginekol (Sofiia); 2004; 43(1):16-20. PubMed ID: 15168648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII.
    Bouwmeester FW; Jonkhoff AR; Verheijen RH; van Geijn HP
    Obstet Gynecol; 2003 Jun; 101(6):1174-6. PubMed ID: 12798521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.